CoChat
Sign Up
Cited by 1

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Assessment and Treatment of Neuropsychiatric Symptoms in Alzheimer’s Disease

Gustavson, Andrew R., Cummings, Jeffrey L.·2004·Alzheimer’s Disease
DOI 10.1007/978-1-59259-661-4_41
Open this paper in CoChat — free account

Abstract

Neuropsychiatric symptoms are a common feature of Alzheimer’s disease (AD). The most common neuropsychiatric symptoms are apathy (72%), aggression/agitation (60%), anxiety (48%), and depression (48%) (1). Patients with psychosis experience a more rapid cognitive decline. The development of these symptoms is particularly problematic for patients and caregivers, and is frequently the factor that leads to nursing home placement. Hence, psychiatric symptoms may be thought of as having a particularly ominous prognostic significance if not detected and treated. Successful complete or partial treatment may reduce patient distress and extend independent living in AD patients (2). Neuropsychiatric symptoms are not always disclosed to physicians by patients or caregivers until they are intolerable, or precipitate a crisis. Routine clinical assessments may allow more proactive clinical management.

Overview

Integrity signals

Registry

Crossref · 10.1007/978-1-59259-661-4_41

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 63

  1. Mega, M.S. et al.: The spectrum of behavioral changes in Alzheimer’s disease. Neurology 1996; 46: 130–135. · DOI
  2. Steele, M.S. et al.: Psychiatric symptoms and nursing home placement of patients with Alzheimer’s disease. Am J Psychiatry 1990; 147: 1049–1051. · DOI · Paper page
  3. Reisberg, B. et al.: Behavioral symptoms in Alzheimer’s disease: phenomenology and treatment. J Clin Psychiatry 1987; 48: 9–15.
  4. Allen, N.P.H. et al.: Manchester and Oxford Universities Scale for the Psychological Assessment of Dementia (MOUSEPAD). Br J Psychiatry 1996; 169: 293–307. · DOI
  5. Tariot, P.N. et al.: The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer’s Disease. Am J Psychiatry 1995; 152: 1349–1357. · DOI
  6. Sultzer, D.L. et al.: Assessment of cognitive, psychiatric, and behavioral disturbances in patients with dementia. J Am Geriatr Soc 1992; 40: 549–555. · DOI
  7. Molloy, D.W. et al.: Validity and reliability of the Dysfunctional Behavior Rating Instrument. Acta Psychiatr Scand 1991; 84: 103–106. · DOI
  8. Alexopoulos, G.S. et al.: Cornell Scale for Depression in Dementia. Biol Psychiatry 1988; 23: 271–284. · DOI · Paper page
  9. Cummings, J.L. et al.: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308–2314. · DOI · Paper page
  10. Buckwalter, K.C.: Overview of psychological factors contributing to stress of family caregivers. In: Radebaugh, T.S. (ed.): Alzheimer’s disease: causes, diagnosis, treatment, and care. CRC Press, New York, 1996: 305–312.
  11. Cohen-Mansfield, J.: Nonpharmacological interventions for inappropriate behaviors in dementia: a review, summary, and critique. Am J Geriatr Psychiatry 2001; 9: 361–381. · DOI · Paper page
  12. Doody, R.S. et al.: Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1154–1166. · DOI
  13. Tariot, P.N. et al.: A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer’s disease in the nursing home setting. J Am Geriatr Soc 2001; 49: 1590–1599. · DOI
  14. Feldman, H. et al.: A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease. Neurology 2001; 57: 613–620. · DOI
  15. Corey-Bloom, J.; Anand, R.; Veach, J.: A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer’s disease: The ENA 713 B352 Study Group. Int J Geriatr Psychopharmacol 1998; 1: 55–65.
  16. Rosler, M. et al.: Effects of two-year treatment with the cholinesterase inhibitor rivastigmine on behavioural symptoms in Alzheimer’s disease. Behav Neurol 1998/1999; 11: 211–216. · DOI
  17. Rosler, M. et al.: Efficacy and safety of rivastigmine in patients with Alzheimer’s disease: international randomized controlled trial. Br Med J 1999; 318: 633–640. · DOI · Paper page
  18. Cummings, J.; Mega, M.: Neuropsychiatry and clinical neuroscience. Oxford University Press, New York, 2003.
  19. Tariot, P.N. et al.: A 5-month, randomized, placebo-controlled trial of galantamine in AD: the Galantamine USA-10 Study Group. Neurology 2000; 54: 2269–2276. · DOI
  20. Tsai, S.J. et al.: Physical aggression and associated factors in probable Alzheimer disease. Alzheimer Dis Assoc Disord 1996; 10: 82–85. · DOI
  21. Tractenberg, R.E.; Weiner, M.F.; Thal, L.7.: Estimating the prevalence of agitation of community-dwelling persons with Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 2002; 14: 11–18. · DOI
  22. Eastley, R.; Wilcock, G.: Prevalence and correlates of aggressive behaviours occurring in patients with Alzheimer’s disease. Int J Geriatr Psychiatry 1997; 12: 484–487. · DOI
  23. Eustace, A. et al.: Verbal aggression in Alzheimer’s disease: clinical, functional, and neuropsychological correlates. Int J Geriatr Psychiatry, 2001; 16: 858–861. · DOI
  24. Teri, L. et al.: Behavioral disturbance, cognitive dysfunction, and functional skill: prevalence and relationship in Alzheimer’s disease. J Am Geriatr Soc 1989; 37: 109–116. · DOI
  25. Devanand, D.P. et al.: The course of psychopathologic features in mild to moderate Alzheimer’s disease. Arch Gen Psychiatry 1997; 54: 257–263. · DOI
  26. Hope, T. et al.: Natural history of behavioural changes and psychiatric symptoms in Alzheimer’s disease. Br J Psychiatry 1999; 174: 39–44. · DOI
  27. Keene, J. et al.: Natural history of aggressive behaviour in dementia. Int J Geriatr Psychiatry 1999; 14: 541–548. · DOI
  28. Cummings, J.L.: Neuropsychiatric aspects of Alzheimer’s disease and related disorders. Martin Dunitz, London, 2002.
  29. Cooper, J.K. et al.: Psychotic symptoms in Alzheimer’s disease. Int J Geriatr Psychiatry 1991; 6: 721–726. · DOI
  30. Gormley, N.; Rizwan, M.R.: Prevalence and clinical correlates of psychotic symptoms in Alzheimer’s disease. Int J Geriatr Psychiatry 1998; 13: 410–414. · DOI
  31. Mendez, M.F. et al.: Psychiatric symptoms associated with Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 1990; 2: 28–33. · DOI
  32. Ballard, C. et al.: The prevalence and phenomenology of psychotic symptoms in dementia sufferers. Int J Geriatr Psychiatry 1995; 10: 477–485. · DOI
  33. Tekin, S. et al.: Activities of daily living in Alzheimer’s disease: neuropsychiatric, cognitive, and medical illness influences. Am J Geriatr Psychiatry 2001; 9: 81–86. · DOI
  34. Binetti, G. et al.: Delusions in Alzheimer’s disease and multi-infarct dementia. Acta Neurol Scand 1993; 88: 5–9. · DOI
  35. Burns, A.; Jacoby, R.; Levy, R.: Psychiatric phenomena in Alzheimer’s disease. I: Disorders of thought content. II: Disorders of perception. Br J Psychiatry 1990; 157: 72–81. · DOI
  36. Hwang, J.-P. et al.: Delusions of theft in dementia of the Alzheimer type: a preliminary report. Alzheimer Dis Assoc Disord 1997; 11: 110–112. · DOI
  37. Mendez, M.F.: Delusional misidentification of persons in dementia. Br J Psychiatry 1992; 160: 414–416. · DOI
  38. Migliorelli, R. et al.: Neuropsychiatric and neuropsychological correlates of delusions in Alzheimer’s disease. Psychol Med 1995; 25: 505–513. · DOI
  39. Chui, H.C. et al.: Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer’s disease. Arch Neurol 1994; 51: 676–681. · DOI
  40. Haupt, M.; Romero, B.; Kurz, A.: Delusions and hallucinations in Alzheimer’s disease: results from a two-year longitudinal study. Int J Geriatr Psychiatry 1996; 11: 965–972. · DOI
  41. Mortimer, J.A. et al.: Predictors of cognitive and functional progression in patients with probable Alzheimer’s disease. Neurology 1992; 42: 1689–1696. · DOI
  42. Stern, Y. et al.: Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer’s disease: prospective analyses from the Predictors Study. Neurology 1994; 44: 2300–2307. · DOI
  43. Wilson, R.S. et al.: Hallucinations, delusions, and cognitive decline in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2000; 69: 172–177. · DOI
  44. Rapoport, M.J. et al.:. Relationship of psychosis to aggression, apathy and function in dementia. Int J Geriatr Psychiatry 2001; 16: 123–130. · DOI
  45. Chemerinski, E. et al.: Prevalence and correlates of aggressive behavior in Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 1998; 10: 421–425. · DOI
  46. Deutsch, L.H. et al.: Psychosis and physical aggression in probable Alzheimer’s disease. Am J Psychiatry 1991; 148: 1159–1163. · DOI
  47. Flynn, F.G.; Cummings, J.L.; Gornbein, J.: Delusions in dementia syndromes: investigation of behavioral and neuropsychological correlates. J Neuropsychiatry Clin Neurosci 1991; 3: 364–370. · DOI
  48. Devanand, D.P. et al.: Depressed mood in the incidence of Alzheimer’s disease in the elderly living in the community. Arch Gen Psychiatry 1996; 53: 175–182. · DOI
  49. Speck, C.E. et al.: History of depression as a risk factor for Alzheimer’s disease. Epidemiology 1995; 6: 366–369. · DOI
  50. Ballard, C. et al.: The prevalence, associations and symptoms of depression amongst dementia sufferers. J Affect Disord 1996; 36: 135–144. · DOI
  51. Lyketsos, C.G. et al.: Major and minor depression in Alzheimer’s disease: prevalence and impact. J Neuropsychiatry Clin Neurosci 1997; 9: 556–561. · DOI
  52. Vida, S. et al.: Prevalence of depression in Alzheimer’s disease and validity of research diagnostic criteria. J Geriatr Psychiatry Neurol 1994; 7: 238–244. · DOI
  53. Weiner, M.F. et al.: Prevalence and incidence of major depressive disorder in Alzheimer’s disease: findings from two databases. Dement Geriatr Cogn Disord 2002; 13: 8–12. · DOI
  54. Burns, A.; Jacoby, R.; Levy, R.: Psychiatric phenomena in Alzheimer’s disease, IV: disorders of behaviour. Br J Psychiatry 1990; 157: 86–94. · DOI
  55. Mackenzie, T.B.; Robiner, W.N.; Knopman, D.: Differences between patient and family assessments of depression in Alzheimer’s disease. Am J Psychiatry, 1989; 146: 1174–1178. · DOI
  56. Olin, J.T. et al.: National Institute of Mental Health provisional diagnostic criteria for depression of Alzheimer disease. Am J Geriatr Psychiatry 2002; 10: 129–141. · DOI
  57. American Psychiatric Association, Diagnostic and statistical manual of mental disorders: DSM-IV ( 4th ed ). American Psychiatric Association, Washington, DC, 1994.
  58. Tiberti, C. et al.: Prevalence and correlates of the catastrophic reaction in Alzheimer’s disease. Neurology 1998; 50: 546–548. · DOI
  59. Lavretsky, H.: Choosing appropriate treatment for geriatric depression. Clin Geriatr 2000; 9 (5): 31–46.
  60. Rao, G.; Constantine, L.G.: The benefits and risks of ECT for patients with primary dementia who also suffer from depression. Int J Ger Psychiatry 2000; 15: 729–735. · DOI
  61. Bliwise, D.L. et al.: Disruptive nocturnal behavior in Parkinson’s disease and Alzheimer’s disease. J Geriatr Psychiatry Neurol 1995; 8: 107–110. · DOI
  62. Geldmacher, D.S.: Contemporary diagnosis and management of Alzheimer’s disease. Handbooks in Health Care Co., Newton, PA, 2001: 200.
  63. Levy, M.L. et al.: Apathy is not depression. J Neuropsychiatry Clin Neurosci 1998; 10: 314–319. · DOI

Cited by

Sorted by citations

Metadata

Authors
Gustavson, A. R., & Cummings, J. L.
Venue
Alzheimer’s Disease
Publisher
Humana Press
Published
2004
Pages
371-385
DOI
10.1007/978-1-59259-661-4_41
Cited by
1
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review